Kouiavskaia D.,CBER HFM 470 |
Collett M.S.,ViroDefense Inc. |
Dragunsky E.M.,CBER HFM 470 |
Sarafanov A.,CBER HFM 470 |
Chumakov K.M.,CBER HFM 470
Clinical and Vaccine Immunology | Year: 2011
Immunization of mice with inactivated polio vaccine (IPV) with concurrent dosing of poliovirus antiviral V-073 showed no detrimental impact on the elicitation of serum-neutralizing antibodies. A strategy involving coadministration of antiviral V-073 and IPV can be considered for the management of poliovirus incidents. Copyright © 2011, American Society for Microbiology. All Rights Reserved.